However, SPCA2 is over-expressed in the plasma membrane of breast cancer cells, where it directly binds to and activates Orai1, independent of STIM1, and leads to enhanced Ca2+ entry and Ca2+-dependent proliferation [227]. Here, STIM1 is linked to breast cancer.